Santos, J. C. d., Haberkorn, U., Mier, W., & Kratochwil, C. (2019). Development and dosimetry of 203Pb/212Pb-labelled PSMA ligands: Bringing "the lead" into PSMA-targeted alpha therapy? European journal of nuclear medicine and molecular imaging, 46(5), . https://doi.org/10.1007/s00259-018-4220-z
Chicago-Zitierstil (17. Ausg.)Santos, José Carlos dos, Uwe Haberkorn, Walter Mier, und Clemens Kratochwil. "Development and Dosimetry of 203Pb/212Pb-labelled PSMA Ligands: Bringing "the Lead" into PSMA-targeted Alpha Therapy?" European Journal of Nuclear Medicine and Molecular Imaging 46, no. 5 (2019). https://doi.org/10.1007/s00259-018-4220-z.
MLA-Zitierstil (9. Ausg.)Santos, José Carlos dos, et al. "Development and Dosimetry of 203Pb/212Pb-labelled PSMA Ligands: Bringing "the Lead" into PSMA-targeted Alpha Therapy?" European Journal of Nuclear Medicine and Molecular Imaging, vol. 46, no. 5, 2019, https://doi.org/10.1007/s00259-018-4220-z.